Chi-East, the independent, pan-Asian trading venue, and Equinix, Inc. (Nasdaq: EQIX), a provider of global data centre services, today announced that Chi-East has chosen Equinix’s Singapore 2 (SG2) International Business Exchange™ (IBX®) as its primary data centre. Chi-East, which commenced operations in the fourth quarter of 2010, is the world’s first exchange-backed, non-displayed trading platform1 for securities listed in Hong Kong, Japan and Singapore.
With the selection of Equinix, Chi-East’s participants will benefit from the data centre provider’s existing carrier and financial network connectivity infrastructure, offering participants low latency proximity hosting options for the 3,264 securities currently supported on Chi-East’s system. This includes all SGX-listed shares, all Hong Kong Main Board listed shares, the component stocks of the TOPIX 100 and all listed ETFs in the three markets.
“One of the unique features of Chi-East is our ability to provide non-displayed trading to clients located throughout Asia from a single location in Singapore. To do this, we have selected a partner that can provide low latency services to our trading participants,” said Ned Phillips, CEO of Chi-East. “We chose Platform Equinix because of its established financial ecosystem, low latency infrastructure and highly secure environment.
“Equinix constantly meets the stringent requirements of the financial community for high performance, connectivity and low latency. We are pleased to support Chi-East in achieving its goal of becoming the first exchange-backed non-display liquidity venue in Asia Pacific,” said David Wilkinson, senior director, business development for Equinix in Asia Pacific.
“The addition of a strong trading venue like Chi-East to the Equinix portfolio showcases our capabilities to provide a neutral environment with optimal connectivity. It further demonstrates how Platform Equinix can provide market participants with access to new business opportunities across multiple locations,” added Wilkinson.
No comments:
Post a Comment